NCT00647231

HKT-500-US12 In Adult Patients With OA Knee Pain

Protocol HKT-500-US12: A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 300 (actual)
• Sponsor: Hisamitsu Pharmaceutical Co., Inc. · Industry
• Sex: All
• Age: 45 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Detailed description

A Randomized, Multicenter, Double-Blind, Single Dose Study of the Analgesic Properties of HKT-500 and Placebo in Subjects with Pain Caused by Mild to Moderate Osteoarthritis of the Knee

Conditions

• Osteoarthritis, Knee

Interventions

Type	Name	Description
DRUG	HKT-500 Topical Patch	Treatment with Ketoprofen Topical Patch
OTHER	Placebo Patch	Treatment with placebo patch

Timeline

• Start date: 2008-03-01
• Primary completion: 2008-08-01
• Completion: 2008-08-01
• First posted: 2008-03-31
• Last updated: 2015-06-04

Locations

29 sites across 1 country: United States